429 related articles for article (PubMed ID: 32576678)
21. Pattern recognition receptors and cytokines in Mycobacterium tuberculosis infection--the double-edged sword?
Hossain MM; Norazmi MN
Biomed Res Int; 2013; 2013():179174. PubMed ID: 24350246
[TBL] [Abstract][Full Text] [Related]
22. Severe Acute Respiratory Syndrome Coronavirus 2: The Role of the Main Components of the Innate Immune System.
Anaeigoudari A; Mollaei HR; Arababadi MK; Nosratabadi R
Inflammation; 2021 Dec; 44(6):2151-2169. PubMed ID: 34524614
[TBL] [Abstract][Full Text] [Related]
23. Pattern recognition receptors and coordinated cellular pathways involved in tuberculosis immunopathogenesis: Emerging concepts and perspectives.
Mishra A; Akhtar S; Jagannath C; Khan A
Mol Immunol; 2017 Jul; 87():240-248. PubMed ID: 28514713
[TBL] [Abstract][Full Text] [Related]
24. Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.
Ma D; Liu S; Lal B; Wei S; Wang S; Zhan D; Zhang H; Lee RS; Gao P; Lopez-Bertoni H; Ying M; Li JJ; Laterra J; Wilson MA; Xia S
Cancer Res; 2019 May; 79(10):2697-2708. PubMed ID: 30898840
[TBL] [Abstract][Full Text] [Related]
25. Innate signaling and regulation of Dendritic cell immunity.
van Vliet SJ; den Dunnen J; Gringhuis SI; Geijtenbeek TB; van Kooyk Y
Curr Opin Immunol; 2007 Aug; 19(4):435-40. PubMed ID: 17629469
[TBL] [Abstract][Full Text] [Related]
26. Recognition of viruses by cytoplasmic sensors.
Wilkins C; Gale M
Curr Opin Immunol; 2010 Feb; 22(1):41-7. PubMed ID: 20061127
[TBL] [Abstract][Full Text] [Related]
27. Innate immunity against HIV-1 infection.
Altfeld M; Gale M
Nat Immunol; 2015 Jun; 16(6):554-62. PubMed ID: 25988887
[TBL] [Abstract][Full Text] [Related]
28. Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.
Liu X; Liu L; Ren Z; Yang K; Xu H; Luan Y; Fu K; Guo J; Peng H; Zhu M; Fu YX
Cell Rep; 2018 Aug; 24(8):2101-2111. PubMed ID: 30134171
[TBL] [Abstract][Full Text] [Related]
29. Emerging phagocytosis checkpoints in cancer immunotherapy.
Liu Y; Wang Y; Yang Y; Weng L; Wu Q; Zhang J; Zhao P; Fang L; Shi Y; Wang P
Signal Transduct Target Ther; 2023 Mar; 8(1):104. PubMed ID: 36882399
[TBL] [Abstract][Full Text] [Related]
30. Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune Responses.
Tukhvatulin AI; Dzharullaeva AS; Tukhvatulina NM; Shcheblyakov DV; Shmarov MM; Dolzhikova IV; Stanhope-Baker P; Naroditsky BS; Gudkov AV; Logunov DY; Gintsburg AL
PLoS One; 2016; 11(5):e0155650. PubMed ID: 27187797
[TBL] [Abstract][Full Text] [Related]
31. Recognition of bacterial infection by innate immune sensors.
Kumar S; Ingle H; Prasad DV; Kumar H
Crit Rev Microbiol; 2013 Aug; 39(3):229-46. PubMed ID: 22866947
[TBL] [Abstract][Full Text] [Related]
32. Development of AO-176, a Next-Generation Humanized Anti-CD47 Antibody with Novel Anticancer Properties and Negligible Red Blood Cell Binding.
Puro RJ; Bouchlaka MN; Hiebsch RR; Capoccia BJ; Donio MJ; Manning PT; Frazier WA; Karr RW; Pereira DS
Mol Cancer Ther; 2020 Mar; 19(3):835-846. PubMed ID: 31879362
[TBL] [Abstract][Full Text] [Related]
33. The role of CD47-SIRPα immune checkpoint in tumor immune evasion and innate immunotherapy.
Li Z; Li Y; Gao J; Fu Y; Hua P; Jing Y; Cai M; Wang H; Tong T
Life Sci; 2021 May; 273():119150. PubMed ID: 33662426
[TBL] [Abstract][Full Text] [Related]
34. CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises.
Tong B; Wang M
Future Oncol; 2018 Sep; 14(21):2179-2188. PubMed ID: 29667847
[TBL] [Abstract][Full Text] [Related]
35. Activation and pathogenic manipulation of the sensors of the innate immune system.
Odendall C; Kagan JC
Microbes Infect; 2017; 19(4-5):229-237. PubMed ID: 28093320
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity.
von Roemeling CA; Wang Y; Qie Y; Yuan H; Zhao H; Liu X; Yang Z; Yang M; Deng W; Bruno KA; Chan CK; Lee AS; Rosenfeld SS; Yun K; Johnson AJ; Mitchell DA; Jiang W; Kim BYS
Nat Commun; 2020 Mar; 11(1):1508. PubMed ID: 32198351
[TBL] [Abstract][Full Text] [Related]
37. The regulation of CD47-SIRPα signaling axis by microRNAs in combination with conventional cytotoxic drugs together with the help of nano-delivery: a choice for therapy?
Beizavi Z; Gheibihayat SM; Moghadasian H; Zare H; Yeganeh BS; Askari H; Vakili S; Tajbakhsh A; Savardashtaki A
Mol Biol Rep; 2021 Jul; 48(7):5707-5722. PubMed ID: 34275112
[TBL] [Abstract][Full Text] [Related]
38. The control of adaptive immune responses by the innate immune system.
Schenten D; Medzhitov R
Adv Immunol; 2011; 109():87-124. PubMed ID: 21569913
[TBL] [Abstract][Full Text] [Related]
39. SIRPα-CD47 Immune Checkpoint Blockade in Anticancer Therapy.
Veillette A; Chen J
Trends Immunol; 2018 Mar; 39(3):173-184. PubMed ID: 29336991
[TBL] [Abstract][Full Text] [Related]
40. Understanding the regulation of "Don't Eat-Me" signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy.
Karizak AZ; Salmasi Z; Gheibihayat SM; Asadi M; Ghasemi Y; Tajbakhsh A; Savardashtaki A
J Cancer Res Clin Oncol; 2023 Jan; 149(1):511-529. PubMed ID: 36342520
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
